PIK3C2A and COVID-19: The results identified an increase in CPK levels, suggestive of muscle damage, one year after an infection by SARS-CoV-2 and also in those patients who developed post-COVID-19 fatigue or post-COVID-19 dyspnea, but not in those reporting post-COVID-19 concentration loss.